See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2016_Ionis_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.1113518197573657, 'aggregate_val': 755315000, 'exp_sum': 357740000, 'exp_to_value': {'LiabilitiesCurrent': 148876000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 208864000}} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.6032273663243315, 'aggregate_val': 812902000, 'exp_sum': 312267000, 'exp_to_value': {'LiabilitiesCurrent': 133784000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 178483000}} |
Graph
Absolute values for 0000874015, Ionis Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 837,003,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 90,233,000 |
| 3 | remainder_Assets | 28,869,000 |
| 4 | LiabilitiesCurrent | 148,876,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 606,439,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 66,698,392 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 436,699,424 |
| 11 | remainder_Revenues | 309,323,726 |
| 12 | remainder_NetIncome | -4,299,882 |
| 13 | remainder_ComprehensiveNetIncome | 18,597,100 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 956,105,000 |
| 1 | Liabilities | 755,315,000 |
| 2 | Expenses | 503,397,816 |
| 3 | Revenues | 309,323,726 |
| 4 | StockholdersEquity | 200,790,000 |
| 5 | NetIncome | -198,373,972 |
| 6 | ComprehensiveNetIncome | -189,075,422 |
| 7 | BaseVar | 1,273,519,262 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.291 |
| 9 | EconomicCapitalRatio | 1.69 |
Edgar->Model Mapping
Feature Distribution
Change over Time
